Ron Lloyd Named Spinal Elements President and CEO

Spinal Elements has appointment Ronald (Ron) Lloyd as president and CEO, succeeding Co-Founder and former President/CEO Jason Blain, who has served as a leader of the organization since the company’s inception as Quantum Orthopedics in 2003.

“Leading Spinal Elements has been the most rewarding and humbling experience of my professional career. I am thankful for all of the colleagues and friends with whom I had the pleasure to serve during those more than 19 years,” Blain said. “I look forward to watching the Spinal Elements team flourish under Ron’s guidance in the coming months and years.”

Lloyd most recently served as president and CEO of Aziyo Biologics, an integrated regenerative medicine company and took the company public in 2020. Before his Aziyo tenure, Lloyd was president of Hospital Therapies at Mallinckrodt Pharmaceuticals and has held senior leadership roles at Baxter International and Abbott Laboratories.

“We are thrilled to add Ron to the Spinal Elements leadership team. Ron brings to Spinal Elements an extensive track record of leadership across the medical device, biological products, pharmaceutical and nutritional products industries,” Board Chairman and Kohlberg Operating Partner Matt Jennings said. “Ron’s combination of commercial expertise and operational depth will help accelerate the next phase of growth at Spinal Elements. We thank Jason for his service to the company and appreciate his ongoing support to the team at Spinal Elements.” 
 
“I have been impressed with the history of innovation here at Spinal Elements. We look forward to recognizing and celebrating that history in 2023, our 20th year of operation,” Lloyd said. “I look forward to applying my experience in commercial strategy to extending the reach of Spinal Elements’ portfolio of innovative solutions, including our novel MIS Ultra product line to a broader base of surgeon customers and patient recipients.”

Most recent releases within the MIS Ultra platform of products and procedural solutions are Karma MIS, the Luna XD Multi-Expandable Interbody System, the Orbit Discectomy System, and the Sapphire X ACDF System. Spinal Elements plans to add new technology innovations to the platform throughout 2023.
 
Headquartered in Carlsbad, Calif., Spinal Elements designs, develops, manufactures, and markets medical devices used in spinal surgeries. The company combines medical device technologies, biologics, and instrumentation to create positive surgical outcomes. The company markets a complete portfolio of advanced spinal implant technologies. The company is backed by Kohlberg & Company LLC, a private equity firm based in Mount Kisco, N.Y. Over its 35 year history, Kohlberg has organized 11 private equity vehicles, through which it has raised more than $13 billion of committed equity capital and generated over $10 billion in realized returns with no realized losses since 2007. Kohlberg employs a white paper research program that results in a higher percentage of proprietary deals and expedient value creation for its portfolio companies.